Clinical Trials Browser

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT03617913 2023-01-06

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

Phase 2 Completed

2 enrolled 8 charts

Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT03174405 2022-09-29

AVETUX

Phase 2 Completed

43 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT04571632 2022-09-14

Luscid

Phase 2 Unknown

36 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

AVESEC

A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma

Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer

Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma

SAMURAI

DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma

Avelumab and M1774 in ARID1A-mutated Endometrial Cancer

A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy

Avelumab and Radiation in Muscle-Invasive Bladder Cancer

Palbociclib After CDK and Endocrine Therapy (PACE)

TALASUR

AXAGIST

Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma

ProTarget

Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer

The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer

SAMCO

LATENT

InCITe

FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC

I-MAT

DISCUS

AVEC-119

PALAVY

AURA

Intermittent Checkpoint Inhibitor Therapy In Patients With Advanced Urothelial Carcinoma

NPC - AXEL Study : Axitinib-Avelumab

AVETRIC

NET-002

Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer

Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy

AVAIL-T

Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPC

EACH

Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3)

ARIES

CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy

Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas

AVENuE

MITO END-3

AVANA

CHASIT

PAVE

Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma

PULSE

Avelumab With Chemoradiation in Locally Advanced Rectal Cancer

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

AVETUX

Luscid